This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Fudan University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yongjun Dang - Innovator in Neurodegenerative Disorder Treatments
Introduction
Yongjun Dang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative disorders. His innovative work has the potential to impact many lives positively.
Latest Patents
Yongjun Dang holds a patent for a compound aimed at treating neurodegenerative disorders. The patent describes the use of a compound with a substituted bicyclic structure, along with its pharmaceutically acceptable salts, stereoisomers, solvates, polymorphs, tautomers, isotopic compounds, metabolites, or prodrugs. This invention is particularly focused on preventing or treating polyglutamine (polyQ) related disorders.
Career Highlights
Yongjun Dang is affiliated with Fudan University, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.
Collaborations
Yongjun has collaborated with notable colleagues, including Boxun Lu and Yiyan Fei. These partnerships enhance the research efforts and contribute to the development of effective treatments.
Conclusion
Yongjun Dang's contributions to the field of neurodegenerative disorder treatments exemplify the impact of innovation in medicine. His work continues to pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile